editorw
appreci
letter
tso
et
al
expand
studi
serolog
profil
sever
acut
respiratori
syndrom
sar
basi
find
studi
certain
igg
antibodi
persist
least
day
onset
symptom
consist
tso
et
al
result
despit
differ
assay
use
indic
sarsassoci
coronaviru
sar
cov
immunoglobulin
titer
continu
increas
day
month
onset
symptom
interestingli
rate
seroconvers
differ
studi
rate
seroconvers
report
studi
rate
seroconvers
report
tso
et
al
studi
may
consequ
differ
popul
patient
differ
assay
use
studi
tso
et
al
select
survivor
group
patient
sar
among
increas
sar
cov
immunoglobulin
singl
titer
first
month
followup
rate
seroconvers
patient
close
observ
day
day
accord
sever
report
immunofluoresc
assay
use
tso
et
al
sensit
elisa
use
studi
nevertheless
elisa
provid
similar
result
remain
conveni
reliabl
test
clinic
practic
epidemiolog
studi
